IN2014CN02163A - - Google Patents

Info

Publication number
IN2014CN02163A
IN2014CN02163A IN2163CHN2014A IN2014CN02163A IN 2014CN02163 A IN2014CN02163 A IN 2014CN02163A IN 2163CHN2014 A IN2163CHN2014 A IN 2163CHN2014A IN 2014CN02163 A IN2014CN02163 A IN 2014CN02163A
Authority
IN
India
Prior art keywords
endos49
igg
mutant
endos
seq
Prior art date
Application number
Other languages
English (en)
Inventor
Mattias Collin
Maria Allhorn
Jonathan Sjögren
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of IN2014CN02163A publication Critical patent/IN2014CN02163A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN2163CHN2014 2011-09-13 2012-09-12 IN2014CN02163A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (1)

Publication Number Publication Date
IN2014CN02163A true IN2014CN02163A (enExample) 2015-05-29

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2163CHN2014 IN2014CN02163A (enExample) 2011-09-13 2012-09-12

Country Status (20)

Country Link
US (1) US9493752B2 (enExample)
EP (1) EP2756077B1 (enExample)
JP (1) JP6076349B2 (enExample)
KR (1) KR102001427B1 (enExample)
CN (1) CN103946377B (enExample)
AU (1) AU2012307461B2 (enExample)
BR (1) BR112014005816A2 (enExample)
CA (1) CA2848230C (enExample)
DK (1) DK2756077T3 (enExample)
EA (1) EA028490B8 (enExample)
ES (1) ES2627334T3 (enExample)
GB (2) GB201115841D0 (enExample)
IL (1) IL231410A0 (enExample)
IN (1) IN2014CN02163A (enExample)
MX (1) MX347727B (enExample)
PL (1) PL2756077T3 (enExample)
PT (1) PT2756077T (enExample)
SG (1) SG11201400505YA (enExample)
WO (1) WO2013037824A1 (enExample)
ZA (1) ZA201401840B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0116704A (pt) * 2000-12-21 2003-12-23 Shire Biochem Inc Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes
HRP20180268T1 (hr) 2012-10-23 2018-03-23 Synaffix B.V. Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
PL2991683T3 (pl) * 2013-05-02 2020-03-31 Glykos Finland Oy Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem
US20160235861A1 (en) 2013-10-14 2016-08-18 SynAffix. B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
JP2016538877A (ja) 2013-10-14 2016-12-15 シンアフィックス ビー.ブイ. 修飾糖タンパク質、タンパク質コンジュゲート及びそれらの調製方法
EP3929301A1 (en) 2013-10-14 2021-12-29 SynAffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
US11168085B2 (en) 2014-01-24 2021-11-09 Synaffix B.V. Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
EP3160513B1 (en) 2014-06-30 2020-02-12 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
WO2016022027A1 (en) 2014-08-04 2016-02-11 Synaffix B.V. Process for the modification of a glycoprotein using a βeta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
PT3134520T (pt) 2015-04-23 2018-03-26 Synaffix Bv Resumo
EP3402815B1 (en) * 2016-01-15 2023-12-06 University of Maryland, College Park Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
SG11201806639VA (en) 2016-02-04 2018-09-27 Genovis Ab New streptococcal proteases
CN110234341A (zh) * 2016-08-24 2019-09-13 醣基生医股份有限公司 利用糖苷内切酶突变体重塑糖蛋白及其使用方法
AU2018272984B2 (en) 2017-05-26 2024-05-23 Genovis Ab Enzymes for glycan analysis
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
CA3102152A1 (en) 2018-06-19 2019-12-26 Glykos Biomedical Oy Conjugate
JP2021529163A (ja) 2018-06-29 2021-10-28 グリコス バイオメディカル オーワイ コンジュゲート
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
KR20220124762A (ko) 2020-01-09 2022-09-14 메르사나 테라퓨틱스, 인코포레이티드 펩티드 함유 링커를 갖는 부위 특이적 항체-약물 접합체
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
US20230374083A1 (en) * 2020-09-21 2023-11-23 Shanghai Bao Pharmaceuticals Co., Ltd. Pharmaceutical combination and use thereof
WO2022147532A1 (en) 2021-01-04 2022-07-07 Mersana Therapeutics, Inc. B7h4-targeted antibody-drug conjugates and methods of use thereof
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
CN117165643B (zh) * 2023-08-17 2025-10-28 山东大学 一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
WO2025098484A1 (zh) * 2023-11-10 2025-05-15 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025180451A1 (zh) * 2024-03-01 2025-09-04 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025248500A1 (en) 2024-05-31 2025-12-04 Janssen Biotech, Inc. Antibody drug conjugates that target enpp3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
DK2190984T3 (da) * 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
CN102511007B (zh) * 2009-10-02 2015-04-15 罗切格利卡特公司 抗体中的a-岩藻糖基化检测

Also Published As

Publication number Publication date
EP2756077A1 (en) 2014-07-23
DK2756077T3 (en) 2017-07-03
MX347727B (es) 2017-05-10
GB201406321D0 (en) 2014-05-21
EA028490B1 (ru) 2017-11-30
KR20140081813A (ko) 2014-07-01
US9493752B2 (en) 2016-11-15
CA2848230A1 (en) 2013-03-21
CN103946377A (zh) 2014-07-23
EA028490B8 (ru) 2018-01-31
PL2756077T3 (pl) 2017-09-29
JP6076349B2 (ja) 2017-02-08
PT2756077T (pt) 2017-06-21
JP2014531205A (ja) 2014-11-27
ZA201401840B (en) 2018-05-30
EA201490447A1 (ru) 2014-09-30
US20140302519A1 (en) 2014-10-09
IL231410A0 (en) 2014-04-30
WO2013037824A1 (en) 2013-03-21
EP2756077B1 (en) 2017-03-29
SG11201400505YA (en) 2014-04-28
KR102001427B1 (ko) 2019-07-18
AU2012307461A1 (en) 2014-03-27
GB2509284A (en) 2014-06-25
ES2627334T3 (es) 2017-07-27
CN103946377B (zh) 2016-10-05
MX2014002906A (es) 2014-10-17
GB201115841D0 (en) 2011-10-26
NZ622172A (en) 2016-04-29
CA2848230C (en) 2020-03-24
BR112014005816A2 (pt) 2020-12-29
AU2012307461B2 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
IN2014CN02163A (enExample)
NZ702962A (en) Agse-deficient strain
WO2012125937A3 (en) Glycosyl hydrolase enzymes and uses thereof for biomass hydrolysis
MX2015000844A (es) Cepa con deficit de amilasa.
IN2014CN01614A (enExample)
PH12017500785A1 (en) INTERFERON a2B VARIANTS
WO2015027258A3 (de) Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
NZ616035A (en) Compositions relating to a mutant clostridium difficile toxin and methods thereof
MX346373B (es) Metodo para preparar harina de grano entero altamente dispersable con un contenido mejorado de avenantramida.
NZ725398A (en) Variants of chymosin with improved milk-clotting properties
MY171544A (en) A cell with reduced ppgppase activity
EA201300876A1 (ru) Мутантная целлобиогидролаза
NZ731727A (en) Method for producing a protein hydrolysate
WO2010101359A3 (ko) L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산 방법
AU2015344324A8 (en) Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution
MX381723B (es) Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa.
EA033091B1 (ru) ПШЕНИЦА С НОВЫМИ АЛЛЕЛЯМИ Rht-B1
MX2012000532A (es) Procesamiento de anticuerpo enzimatico.
NZ707753A (en) Purification of recombinant human galactocerebroside β-galactosidase (rhgalc)
CA2868057C (en) Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
WO2009129086A3 (en) Endoglycosidases that cleave o-linked glycans
WO2011124925A3 (en) Polysaccharide degrading enzymes from coleoptera
WO2011107483A3 (en) Enzyme aspartokinase iii having a reduced l-lysine feedback inhibition
WO2010146555A3 (en) Automatic setting system for mosaic